| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. | J Clin Oncol | 2008 | 4.82 |
| 2 | Small cell lung cancer. | J Natl Compr Canc Netw | 2011 | 1.07 |
| 3 | A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy. | Invest New Drugs | 2008 | 0.83 |